Indaco Venture Partners and Medical Incubator Japan led a €23m Series A round in Hoba Therapeutics.

Indaco Venture Partners, a venture capital asset management company, and Medical Incubator Japan, an investment company, led a €23m Series A round in Hoba Therapeutics, a biotech developing restorative treatments for chronic pain disorders and hearing loss, with participation from Novo, Eir Ventures, and the Export and Investment Fund of Denmark, "We are thrilled to close the first round of the Series A. This is an experienced investor syndicate backing Hoba Therapeutics. In addition to the participation of our current investors, we have strengthened the syndicate with the participation of funds from Europe and Japan, along with strong support from The European Innovation Council Fund. This shows the shared perspective on the large unmet need we aim to fill and reflects our focus and commitment to help patients worldwide and we believe that these funds can contribute significantly to achieving our objectives," Torsten M. Madsen, Hoba Therapeutics CEO.